XGN's Market share relative to its competitors, as of Q3 2025

As of Q3 2025 (Revenue in Millions of $)

Date modified: 2025-11-19T04:47:18+00:00

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Market Share▼

Download as CSV

COMPANY NAME	REVENUES 12 Months Ending Q3 2025	MARKET SHARE 12 Months Q3 2025	MARKET SHARE MRQ Q3 2025	MARKET SHARE A Quarter Before Q2 2025
Exagen Inc	61.72	0.21%	0.22 %	0.22 %
Labcorp Holdings Inc	13,765.30	45.94%	46.16%	46.90%
Quest Diagnostics Inc	10,850.00	36.21%	36.48%	36.71%
Horizon Therapeutics Public Limited Company	3,643.45	12.16%	12.23%	11.06%
Myriad Genetics Inc	823.20	2.75%	2.65%	2.83%
Opko Health Inc	642.07	2.14%	1.96%	2.08%
First Choice Healthcare Solutions Inc	86.33	0.29%	0.00%	0.00%
Mdxhealth Sa	70.19	0.23%	0.23%	0.00%
Psychemedics Corporation	19.10	0.06%	0.06%	0.07%
Ispecimen Inc	4.54	0.02%	0.00%	0.01%
SUBTOTAL	29,965.89	100%	7,719.09	100%

XGN's Market share relative to its competitors, as of Q3 2025 within the Medical Laboratories Industry

As of Q3 2025

COMPANY NAME	MARKET SHARE 12 Months Ending Q3 2025	MARKET SHARE 12 Months Ending Q2 2025	MARKET SHARE MRQ Q3 2025	MARKET SHARE Q2 2025
Exagen Inc	0.25%	0.24%	0.27 %	0.26 %
Labcorp Holdings Inc	55.38%	55.68%	55.52%	55.81%
Quest Diagnostics Inc	43.65%	43.45%	43.87%	43.69%
First Choice Healthcare Solutions Inc	0.35%	0.37%	0.00%	0.00%
Mdxhealth Sa	0.28%	0.15%	0.28%	0.15%
Psychemedics Corporation	0.08%	0.08%	0.07%	0.08%
Ispecimen Inc	0.02%	0.03%	0.00%	0.01%
SUBTOTAL	100%	100%	100%	100%

XGN's Market share relative to its competitors, as of Q3 2025 within the Healthcare Sector

As of Q3 2025

COMPANY NAME	MARKET SHARE 12 Months Ending Q3 2025	MARKET SHARE 12 Months Ending Q2 2025	MARKET SHARE MRQ Q3 2025	MARKET SHARE Q2 2025
Exagen Inc	0.21%	0.20%	0.22 %	0.22 %
Labcorp Holdings Inc	45.94%	46.04%	46.16%	46.90%
Quest Diagnostics Inc	36.21%	35.92%	36.48%	36.71%
Horizon Therapeutics Public Limited Company	12.16%	12.21%	12.23%	11.06%
Myriad Genetics Inc	2.75%	2.84%	2.65%	2.83%
Opko Health Inc	2.14%	2.27%	1.96%	2.08%
First Choice Healthcare Solutions Inc	0.29%	0.31%	0.00%	0.00%
Mdxhealth Sa	0.23%	0.13%	0.23%	0.13%
Psychemedics Corporation	0.06%	0.07%	0.06%	0.07%
Ispecimen Inc	0.02%	0.02%	0.00%	0.01%
SUBTOTAL	100%	100%	100%	100%

Note: Market share is calculated based on total revenue. To get a more accurate picture of Exagen Inc's market divisions, geographic dispersion, segments, products, and services, visit Exagen Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.